BMY
Price:
$58.8
Market Cap:
$119.26B
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; Eliquis, an oral inhibitor for reduction in risk of stroke/systemic embolism in NVAF, and for the treatment of DVT/PE; Opdivo for anti-cancer indications; Pomalyst/Imnovid indicated for patients with multiple myeloma; and Orencia for adult patients with active RA and psoriatic arthritis. It also provides Sprycel for the treatment of Philadelphi...[Read more]
Industry
Drug Manufacturers - General
IPO Date
1972-06-01
Stock Exchange
NYSE
Ticker
BMY
According to Bristol-Myers Squibb Company’s latest financial reports and current stock price. The company's current Enterprise Value is 161.12B. This represents a change of 13.56% compared to the average of 141.87B of the last 4 quarters.
The mean historical Enterprise Value of Bristol-Myers Squibb Company over the last ten years is 132.08B. The current 161.12B Enterprise Value has changed 12.10% with respect to the historical average. Over the past ten years (40 quarters), BMY's Enterprise Value was at its highest in in the June 2022 quarter at 196.53B. The Enterprise Value was at its lowest in in the June 2019 quarter at 72.18B.
Average
132.08B
Median
127.57B
Minimum
85.32B
Maximum
184.85B
Discovering the peaks and valleys of Bristol-Myers Squibb Company Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 69.52%
Maximum Annual Enterprise Value = 184.85B
Minimum Annual Increase = -26.34%
Minimum Annual Enterprise Value = 85.32B
Year | Enterprise Value | Change |
---|---|---|
2023 | 136.16B | -26.34% |
2022 | 184.85B | 8.67% |
2021 | 170.10B | -4.00% |
2020 | 177.19B | 22.51% |
2019 | 144.64B | 69.52% |
2018 | 85.32B | -17.44% |
2017 | 103.35B | 3.22% |
2016 | 100.12B | -15.85% |
2015 | 118.98B | 18.89% |
2014 | 100.07B | 8.62% |
The current Enterprise Value of Bristol-Myers Squibb Company (BMY) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
163.70B
5-year avg
162.59B
10-year avg
132.08B
Bristol-Myers Squibb Company’s Enterprise Value is less than AbbVie Inc. (365.28B), less than Merck & Co., Inc. (273.07B), greater than Gilead Sciences, Inc. (115.15B), less than Johnson & Johnson (381.81B), less than Eli Lilly and Company (785.67B), less than Pfizer Inc. (207.34B), less than Amgen Inc. (210.43B), greater than Biogen Inc. (27.58B),
Company | Enterprise Value | Market cap |
---|---|---|
365.28B | $301.46B | |
273.07B | $249.53B | |
115.15B | $115.15B | |
381.81B | $366.03B | |
785.67B | $757.91B | |
207.34B | $150.43B | |
210.43B | $159.05B | |
27.58B | $24.38B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bristol-Myers Squibb Company using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Bristol-Myers Squibb Company or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Bristol-Myers Squibb Company's Enterprise Value?
What is the highest Enterprise Value for Bristol-Myers Squibb Company (BMY)?
What is the 3-year average Enterprise Value for Bristol-Myers Squibb Company (BMY)?
What is the 5-year average Enterprise Value for Bristol-Myers Squibb Company (BMY)?
How does the current Enterprise Value for Bristol-Myers Squibb Company (BMY) compare to its historical average?